Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Ono Pharmaceutical
Ono Pharmaceutical
Activities:
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Research & Development
Bristol-Myers Squibb and Ono Pharmaceutical agree immuno-oncology collaboration
Japan, South Korea and Taiwan
Manufacturing
AMRI and Ono extend drug discovery pact
Will collaborate on hit-to-lead and lead optimisation for two new molecules
Research & Development
BioFocus and Ono sign CNS drug discovery agreement
BioFocus will use its drug discovery platform to deliver leads and clinical candidates
Finance
Merck Serono and Ono to co-operate
On multiple sclerosis and cancer therapies
Research & Development
Xention and Ono extend drug discovery agreement
Collaboration to continue for a third year
Regulatory
BioSeek and Ono agree research collaboration
BioSeek will apply its BioMAP technology to Ono drug target
Subscribe now